Cited 34 time in
Comparative Characterization of Porcine Mesenchymal Stem Cells Derived from Bone Marrow Extract and Skin Tissues
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ock, Sun-A | - |
| dc.contributor.author | Jeon, Byeong-Gyun | - |
| dc.contributor.author | Rho, Gyu-Jin | - |
| dc.date.accessioned | 2022-12-27T04:02:59Z | - |
| dc.date.available | 2022-12-27T04:02:59Z | - |
| dc.date.issued | 2010-12 | - |
| dc.identifier.issn | 1937-3384 | - |
| dc.identifier.issn | 1937-3392 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/24849 | - |
| dc.description.abstract | Mesenchymal stem cells (MSCs) offer a great promise for regenerative medicine. Present study compared the characterization of porcine MSCs (pMSCs) derived from bone marrow extract with adult ear and fetal skin-derived cells on morphology, cell growth, alkaline phosphatase activity, proliferation ability, expression of cluster of differentiation (CD) markers (CD29, 45, and 90), cell cycle, protein and mRNA levels of Oct-4, Sox-2, and Nanog, and lineage differentiation ability. Skin-derived cells exhibited alkaline phosphatase activity and differentiation ability like pMSCs. pMSCs possessed a longer doubling time than skin-derived cells, and there was no difference in the ratio of G0/G1 phase between pMSCs and skin-derived cells. Except for CD29 and 90, all cells were found negative for CD45. Protein and mRNA expression of Oct-4, Sox-2 and Nanog were observed with similar intensity in all cells. Taken together, pMSCs and skin-derived cells revealed similar characteristics, and suggested the possible supportive role of skin-derived cells with MSCs for the regeneration of damaged tissues in cell-based therapies. | - |
| dc.format.extent | 11 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | MARY ANN LIEBERT, INC | - |
| dc.title | Comparative Characterization of Porcine Mesenchymal Stem Cells Derived from Bone Marrow Extract and Skin Tissues | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1089/ten.tec.2010.0149 | - |
| dc.identifier.scopusid | 2-s2.0-78649662116 | - |
| dc.identifier.wosid | 000284627000026 | - |
| dc.identifier.bibliographicCitation | TISSUE ENGINEERING PART C-METHODS, v.16, no.6, pp 1481 - 1491 | - |
| dc.citation.title | TISSUE ENGINEERING PART C-METHODS | - |
| dc.citation.volume | 16 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 1481 | - |
| dc.citation.endPage | 1491 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Cell Biology | - |
| dc.relation.journalResearchArea | Engineering | - |
| dc.relation.journalResearchArea | Materials Science | - |
| dc.relation.journalWebOfScienceCategory | Cell & Tissue Engineering | - |
| dc.relation.journalWebOfScienceCategory | Cell Biology | - |
| dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
| dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
| dc.subject.keywordPlus | NUCLEAR TRANSFER | - |
| dc.subject.keywordPlus | PROGENITOR CELLS | - |
| dc.subject.keywordPlus | EXPRESSION | - |
| dc.subject.keywordPlus | EMBRYOS | - |
| dc.subject.keywordPlus | NANOG | - |
| dc.subject.keywordPlus | SWINE | - |
| dc.subject.keywordPlus | OCT-4 | - |
| dc.subject.keywordPlus | DIFFERENTIATION | - |
| dc.subject.keywordPlus | PLURIPOTENCY | - |
| dc.subject.keywordPlus | LINEAGES | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
